MERIDICA

Drug delivery systems sold filled with pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations, ophthalmological preparations

Drug delivery systems comprised of a dry powder inhaler; drug delivery systems, namely, a device for nasal delivery of pre-metered doses of pharmaceuticals in dry powder format; drug delivery systems, namely, a device that provides breath-actuated delivery of drugs from pressurized metered dose inhalers; drug delivery systems, namely, metering and measuring automated and programmable equipment for measuring and metering drugs into capsules and other solid dose form containers

Diagnostic services in the field of drug delivery systems; exploitation and licensing of intellectual property and intellectual property rights

Medical services for the treatment of medical diseases, illnesses and conditions in the therapeutic areas of central nervous system (CNS), endocrine disorders, musculoskeletal, anti-viral, pain control, sexual dysfunction, anti-addictive, vaccines, respiratory, and allergies